Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology Reports"
DOI: 10.1007/s11912-022-01241-z
Abstract: The reintroduction of immune checkpoint inhibitors (ICIs) after disease progression (rechallenge) or immune-related adverse events (irAEs) recovering (resumption) raises questions in terms of efficacy and safety. Here, we reviewed literature data about ICIs rechallenge/resumption in… read more here.
Keywords: rechallenge resumption; checkpoint inhibitor; resumption; immune checkpoint ... See more keywords